Praxis Precision Medicines, Inc. PRAX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets?
- Praxis Precision Medicines, Inc. (PRAX) reported operating lease right-of-use assets in other assets of $1.32M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets increased by 49.7% year-over-year, from $882K to $1.32M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s operating lease right-of-use assets in other assets has grown at a -34.3% compound annual growth rate (CAGR), from $754K to $92K.